Skip to content

Abdominal Sacral Hysteropexy Versus Vaginal Sacrospinous Hysteropexy

Comparison Between Abdominal Sacral Hysteropexy and Vaginal Sacrospinous Hysteropexy for Management of Women With Apical Uterine Descent : a Randomized Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04850365
Enrollment
70
Registered
2021-04-20
Start date
2020-01-01
Completion date
2022-11-30
Last updated
2022-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Organ Prolapse

Brief summary

The aim of the current study is to compare abdominal sacral cervicopexy with vaginal sacrospinous cervicopexy in women with apical prolapse in terms of operative time, procedures safety and efficacy.

Detailed description

According to Cochrane group trials , abdominal approaches centered on sacral colpopexy is associated with lower risk of awareness of prolapse, repeat surgery for prolapse and dyspareunia than a variety of vaginal interventions. However, these trials weren't statistically significant and have focused on the effects in terms of anatomy and lacked the effect on functional outcomes, the quality of life, perioperative complications and the operative duration. In this study, We hypothesize that prolonged operative duration will be associated with a greater risk of developing complications and so may guide us to a minimally invasive approach with better functional outcomes.

Interventions

PROCEDUREHysteropexy

Abdominal Sacral cervicopexy: The approach involves suspending the cervix to the anterior longitudinal ligament on the sacrum using permanent sutures or polypropylene mesh. Vaginal Sacrospinous cervicopexy: This transvaginal extraperitoneal technique involves suspending the sacrospinous ligament to the cervix using either a dissolvable or permanent suture. The suspension is performed in a unilateral fashion.

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* In order to be eligible to participate in this study, a subject must meet all of the following criteria: 1. Symptomatic apical descent stage II or more. 2. Eligible for both surgical procedures 3. No uterine or cervical pathology. 4. Able to consent to participate in the trial.

Exclusion criteria

1. Women with contraindication to any surgical procedures. 2. Women with previous apical prolapse surgery. 3. One of the two surgical approaches is not feasible. 4. Women with concomitant surgical procedures apart from correction of the prolapse. 5. Women who prefer to have hysterectomy.

Design outcomes

Primary

MeasureTime frameDescription
Operative timeintraoperativeOperative time will be recorded starting from skin incision.

Secondary

MeasureTime frameDescription
a_clinical effectiveness assessed by the pelvic organ prolapse quantification system (POP_Q).From 6 months to 1 year follow upThe patients will be followed for recurrence of the symptoms and the degree of descent.
b_Number of participants with treatment_related adverse events as assessed by CTCAE v4.0From 6 months to 1 year follow upIt will be used to assess the safety and tolerability to the procedure.

Countries

Egypt

Contacts

Primary ContactAsmaa Ragab Mady
dr.asmaa.r.mady@gmail.com0201011431780

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026